tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market
Holding NAMS?
Track your performance easily

NewAmsterdam Pharma Company (NAMS) Hedge Fund Trading Activity

122 Followers
Trend: â–˛ Hedge Funds Increased Holdings by 937.9K Shares Last Quarter

Hedge Fund Holdings in NAMS

Based on the 13F filings of 487 Hedge Funds submitted to the SEC.
See how hedge fund holdings have changed over the past year. The columns represent the number of shares owned by hedge funds.

Hedge Fund Confidence Signal

Positive
Stock Sentiment
Sold
Bought
Based on activity of 8 Hedge Funds in the recent quarter
A unique signal which shows hedge fund sentiment according to recent transactions.

Hedge Fund Activity​

Activity
Any
Any
Star Ranking
Any
Any
Hedge Fund Manager
Star Ranking
Firm
Activity
Holding Change
Value Reported
% of Portfolio
Follow
Gilder Gagnon Howe & Co LLC.
Reduced
-1.90%
$397105
<0.01%
Baker Bros Advisors LP
Reduced
-0.12%
$1605402
0.02%
Duquesne Family Office LLC
New
100.00%
$4773081
0.16%
GMT Capital Corp
Reduced
-7.04%
$13761997
0.55%
Deerfield Management Company, LP
Added
3.74%
$14969050
0.22%
Woodline Partners LP
Added
140.94%
$19333638
0.16%
Viking Global Investors LP
Not Changed
0.00%
$133207779
0.49%
RA Capital Management
Not Changed
0.00%
$133862400
1.54%

FAQ

Which hedge funds hold NewAmsterdam Pharma Company?
The hedge funds that hold the most shares in NewAmsterdam Pharma Company are Peter Kolchinsky, Andreas Halvorsen and Michael Rockefeller.
    Are hedge funds buying or selling NAMS?
    In the last quarter hedge funds have Increased their holdings in NewAmsterdam Pharma Company by 937.9K shares.
      Where can I see a list of the best rated hedge funds?
      You can see a list of the best hedge funds here.
        Who is the best-performing hedge fund manager?
        The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
          Does Warren Buffet hold shares in NewAmsterdam Pharma Company stock?
          Warren Buffet currently does not own shares in NewAmsterdam Pharma Company.
          What is a 13F filing, and how does it help investors?
          A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis